Skip to main content
logo
Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
34.43
-0.46 (-1.32%)
Aug 20, 2026, 3:33 PM EDT - Market open

Alto Neuroscience Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-84.24-63.24-61.43-36.31-27.71-9.19
Depreciation & Amortization
0.690.660.50.370.340.15
Loss (Gain) From Sale of Assets
0.120.160.050.14--
Asset Writedown & Restructuring Costs
--0.74---
Stock-Based Compensation
10.518.117.632.891.760.23
Other Operating Activities
1.982.511.030.150.630.13
Change in Accounts Receivable
----1.16-1.29
Change in Accounts Payable
2.310.220.52-0.631.010.46
Change in Other Net Operating Assets
0.34-0.193.54-0.072.420.26
Operating Cash Flow
-68.29-51.77-47.42-33.45-20.39-9.26
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.56-0.02-2.08-0.47-0.73-0.68
Investing Cash Flow
-0.56-0.02-2.08-0.47-0.73-0.68

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-20.441.25-9.83-
Long-Term Debt Repaid
--10.21----
Net Debt Issued (Repaid)
-10.231.25-9.83-
Issuance of Common Stock
170.5950.7137.770.180.040.01
Other Financing Activities
-5.39-0.85-3.33-2.05-0.34-0.21
Financing Cash Flow
165.0160.08135.6968.1343.7931.69

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.02-0.03-0.01-0.01-0.02-0.05
Net Cash Flow
96.158.2686.1834.222.6421.7

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-68.84-51.79-49.5-33.92-21.13-9.94
Free Cash Flow Growth
------
Free Cash Flow Margin
------4734.29%
Free Cash Flow Per Share
-1.94-1.79-2.01-9.09-6.13-4.12
Levered Free Cash Flow
-42.9-33.95-32.29-23.45-12.3-
Unlevered Free Cash Flow
-41.48-32.41-31.44-22.6-12.3-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
1.571.6610.91--
Change in Working Capital
2.650.034.06-0.74.58-0.57
SEC Filings: 10-K · 10-Q